Popular diabetes and obesity drugs also protect kidneys, study shows
The biggest and most comprehensive analysis of glucagon-like peptide-1 (GLP-1) receptor agonists on kidney and cardiovascular outcomes shows they have significant benefits in people with and without diabetes.
Study Finds Popular Diabetes and Obesity Drugs Also Safeguard Kidneys
A new study shows GLP-1 receptor agonists offer significant protection for kidneys and heart in both diabetic and non-diabetic individuals.
Weight loss, diabetes drugs can also protect kidneys: Study
The popular glucagon-like peptide-1 (GLP-1) receptor agonists known to help in weight loss as well as manage blood sugar can also protect the kidneys, regardless of diabetes status, finds a study led by an Indian-origin researcher.
Weight-loss drugs can improve kidney health, study finds
Weight-loss drugs can reduce the risk of worsening kidney function, kidney failure and dying from kidney disease by a fifth, according to a study. Glucagon-like peptide-1 (GLP-1) receptor agonists are a family of medications that help people shed the pounds,
Diabetes drug shows promise in protecting kidneys
Researchers evaluated the effects of SGLT2 inhibitors in protecting the kidneys, showing that the drugs might help improve oxygenation in these organs.
Popular diabetes and obesity drugs also protect kidneys, study suggests
Popular diabetes and obesity drugs also protect kidneys, study suggests - The combined reduction in the risk of kidney failure, worsening kidney function and death due to kidney disease was 19%, researchers found.
CMAJ1d
Glucagon-like peptide-1 receptor agonists for treating chronic kidney disease in patients with type 2 diabetes
In a randomized controlled trial of people with type 2 diabetes, albuminuria, and estimated glomerular filtration rate (eGFR) ...
HealthDay on MSN5d
Glucagon-Like Peptide-1 Receptor Agonists May Reduce Alcohol Consumption
Glucagon-like peptide-1 receptor agonist (GLP-1 RA) use may reduce alcohol consumption and improve outcomes in some ...
News Medical2d
GLP-1 receptor agonists prove effective for kidney and cardiovascular outcomes
The biggest and most comprehensive analysis of glucagon-like peptide-1 (GLP-1) receptor agonists on kidney and cardiovascular outcomes shows they have significant benefits in people with and ...
New Atlas2d
Injectable anti-obesity drugs shown to benefit heart health
A collection of studies presented at a recent American Heart Association (AHA) conference has confirmed the heart health benefits provided by the new anti-obesity drugs, semaglutide and tirzepatide, ...
Daily7d
Glucagon-like peptide-1 receptor Agonists can effectively control Alcohol Use Disorder, finds study
A recent study found that glucagon-like peptide-1 receptor (GLP-1) agonists like semaglutide and liraglutide are effective in ...
Newsday15h
Wegovy, Mounjaro: Suffolk County among employers rethinking access to costly weight loss drugs
Those on the medications, known as GLP-1s or glucagon-like peptide-1, will additionally weigh in four times a month on ...
Too Old to Operate1d
GLP-1 Receptor Agonists and Hepatocellular Carcinoma Risk in Diabetes
The following is a summary of “Risk of Hepatocellular Carcinoma with Glucagon-like Peptide-1 receptor agonist treatment in patients: a systematic review and meta-analysis,” published in the November ...
News Medical on MSN7d
Impact of glucagon-like peptide-1 receptor agonists on alcohol consumption
The impact of GLP-1 RAs on alcohol use is explored, showing potential benefits in reducing intake and cravings, but with ...
7 Ways To Naturally Optimize Your GLP-1 Response & Lose Weight Fast
A registered dietitian shares the best diet and exercise tips to help optimize your GLP-1 response for faster weight loss.